Insider Trading April 15, 2026 06:28 PM

CoreWeave Director Disposes $124.6M in Class A Shares; Company Reports Major Deals and Debt Raises

Brian Venturo executed a large sale under a 10b5-1 plan as CoreWeave discloses conversions and multi-billion-dollar strategic and financing moves

By Caleb Monroe CRWV
CoreWeave Director Disposes $124.6M in Class A Shares; Company Reports Major Deals and Debt Raises
CRWV

CoreWeave director and Chief Strategy Officer Brian M. Venturo sold $124.6 million of Class A Common Stock on April 13, 2026, under a pre-arranged 10b5-1 plan, according to an SEC Form 4 filing. The transactions coincided with conversions of Class B shares to Class A and followed a period of rapid share-price appreciation. The firm also disclosed sizable commercial arrangements and recent private debt offerings, while analysts revised price targets in response to the company updates.

Key Points

  • Venturo sold $124.6 million of Class A Common Stock on April 13, 2026, under a pre-arranged 10b5-1 trading plan; sale prices ranged from $104.7966 to $113.8805.
  • Shares sold were held indirectly via West Clay Capital LLC (488,394 shares) and the Venturo Family GST Exempt Trust dated June 30, 2023 (224,924 shares); conversions of Class B to Class A also occurred on the same day.
  • CoreWeave announced major commercial and financing activity including a roughly $6 billion access arrangement with Jane Street, a $1 billion equity purchase by Jane Street at $109.00 per share, $4 billion in Convertible Senior Notes, and $1.75 million in Senior Notes; analysts adjusted price targets following these developments.

CoreWeave, Inc. reported a substantial insider sale on April 13, 2026, when Brian M. Venturo, the company’s Chief Strategy Officer and a director, disposed of Class A Common Stock in a transaction documented on a Form 4 filed with the Securities and Exchange Commission. The disposition, executed under a pre-established 10b5-1 trading plan, totaled $124.6 million and included shares sold at prices spanning $104.7966 to $113.8805.

The filing shows the shares sold were held indirectly through two entities: West Clay Capital LLC and the Venturo Family GST Exempt Trust dated June 30, 2023. West Clay Capital LLC sold 488,394 shares, and the Venturo Family GST Exempt Trust sold 224,924 shares as part of the transactions reported on the Form 4.

On the same date as the sales, the filing indicates Venturo enacted conversions of Class B Common Stock into Class A Common Stock. Specifically, 900,000 shares of Class B Common Stock controlled by West Clay Capital LLC were converted to Class A Common Stock, and 225,000 shares of Class B Common Stock controlled by the Venturo Family GST Exempt Trust were likewise converted to Class A Common Stock.

The insider activity comes amid a period of strong market performance for CoreWeave. Shares of CoreWeave have risen 191% over the last year and were trading at $118.69 at the time of reporting, with the company carrying a market capitalization of $61.6 billion. Analysis flagged in the filing notes that InvestingPro views the stock as overvalued relative to its Fair Value and places it in overbought territory.


Beyond the insider transactions, CoreWeave announced several material commercial and financing developments that have drawn investor attention. The company disclosed an expansion of its relationship with Jane Street that involves approximately $6 billion for access to CoreWeave’s artificial intelligence compute infrastructure. Alongside that access arrangement, Jane Street invested $1 billion in CoreWeave’s Class A common stock, acquiring shares at $109.00 each. The expansion is described as incorporating NVIDIA’s Vera Rubin platform together with CoreWeave’s software and services stack.

In addition to the Jane Street agreement, the company reported completion of two private debt offerings. The first raised $4 billion through Convertible Senior Notes, and the second raised $1.75 million in Senior Notes. The Convertible Senior Notes are scheduled to mature in 2032, carry an interest rate of 1.75% per year, and are convertible into cash or CoreWeave common stock.

Analyst coverage reacted to the announcements. Evercore ISI raised its price target on CoreWeave to $150 from $120 and kept an Outperform rating following the Jane Street transaction. Separately, Bernstein SocGen Group increased its price target to $67 from $56 while maintaining an Underperform rating; that change was made after the company disclosed new agreements including a $21 billion deal with Meta and an additional agreement with Anthropic.


The Form 4 filing documents and the corporate updates together lay out a mix of insider liquidity actions, equity-class conversions, large-scale commercial partnerships, and significant debt financing. Each disclosure in the paperwork and public announcements is a matter of record in regulatory filings and company statements.

This article presents the facts reported in the company filings and announcements without analysis beyond the information disclosed in those documents.

Risks

  • Insider sale of a large block of stock could be viewed negatively by some market participants and may affect investor sentiment - impacts equity markets and investor confidence.
  • Analyst divergence on valuation and ratings, including notes that the stock may be overvalued relative to Fair Value and overbought, introduces uncertainty about near-term price direction - impacts equity valuation assessments.
  • The company’s recent debt raises and convertible notes introduce financial obligations and dilution options; the Convertible Notes are due in 2032 with a 1.75% interest rate and are convertible into cash or stock - impacts capital structure and fixed-income markets.

More from Insider Trading

Charles Schwab Risk Chief Sells $4.08M in Stock, Exercises Equivalent Options Ahead of Earnings Apr 15, 2026 Airwa Director Adds to Stake as Company Completes $140M Acquisition Apr 15, 2026 Photronics Director Sells $225,000 in Stock After Exercising Options; Company Posts Quarterly Beat and Advances Mask Capability Apr 15, 2026 Genprex Director Disposes of Small Holding as Company Advances Gene Therapy IP and Data Presentations Apr 15, 2026 Arista CEO Jayshree Ullal Sells $16.9M in ANET Stock Under 10b5-1 Plan Apr 15, 2026